People in the News: BioMerieux Appoints New Directors; Exosome Hires Kelly as CFO | GenomeWeb

BioMérieux this week appointed of two new independent directors, Agnès Lemarchand and Philippe Gillet. Lemarchand and Gillet are replacing Georges Hibon and Michel Angé, who did not wish to renew their terms on the company's board.

Lemarchand has served as CEO of Industrie Biologique Française, a joint venture between the Rhône-Poulenc group and Institut Mérieux. She has also served as chairman and CEO of Prodical, a subsidiary of the Ciments Français group; and chairman and CEO of the Lafarge group's lime business.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.

In PLOS this week: cell-free DNA from tumors is shorter than DNA from healthy cells, type 2 diabetes-related loci, and more.

Genetic analysis confirms that blood found on leaves collected near Marche-les-Dames some 80 years ago belongs to King Albert I of Belgium.

Researchers in the US begin to seek participants for the 1 million-person precision medicine cohort, the New York Times reports.

A new report indicates that women are underrepresented among US patent holders.